Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2026-05-14
Summary
The purpose of this study is to answer: how do inflammation and anti-inflammatory skin therapies work in the skin? Inflammation is a protective response from the body's immune system to injury, disease, or irritation. It is a process by which your body's white blood cells and the things they make protect you from infection from outside invaders such as bacteria and viruses.
Conditions
- Skin Inflammation
- Allergic Contact Dermatitis
Interventions
- DRUG
-
Squaric Acid Dibutyl Ester
Sensitization dose: 2% Elicitation doses: {0.0001%, 0.00025%, 0.00075%, 0.001%, 0.0025%, 0.005%, 0.0075%, 0.01%, 0.025%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6% 0.7%, 0.8%, 0.9%, 1.0%, 1.2%, 1.4%, 1.6%, 1.8%, 2.0%}
- OTHER
-
Known patch test allergens
Positive patch test allergens during the course of clinical patch testing will be re-applied on the back followed by skin sampling
- DRUG
-
300mg
- DRUG
-
40mg
- DRUG
-
45mg
- DRUG
-
Guselkumab
100mg
- DRUG
-
Canakinumab
150mg
- DRUG
-
Sarilumab
200mg
- DRUG
-
Triamcinolone Acetonide
0.1% ointment
- DRUG
-
Betamethasone Valerate
0.1% ointment
- DRUG
-
Fluticasone Propionate
0.005% ointment
- DEVICE
-
Microneedle
Painless and non-scarring skin sampling with a 7mm x 7mm patch of hydrogel-coated poly-l-lactide microneedles (\<2mm length) will be used to collect interstitial fluid
- DEVICE
-
Suction blistering
Suction blistering is a technique to induce and collect blister fluid using a negative pressure instrument (Electronic Diversities Finksburg, MD). It does not require local anesthetic, stitches or pain medication following the procedure. The blisters will be no greater than 1cm in diameter and no deeper than the epidermis (\<1mm deep). This process of inducing blisters is typically less than 1 hour. After the formation of blisters, the blister fluid will be extracted using a syringe. The blister roofs will be left attached to the skin and covered with petrolatum and a bandage.
- PROCEDURE
-
Skin punch biopsy
A skin biopsy is the removal of a small piece of tissue, under local anesthetic.
Sponsors & Collaborators
-
Wei-Che Ko
lead OTHER
Principal Investigators
-
Wei-Che Ko, MD · University of Massachusetts, Worcester
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-15
- Primary Completion
- 2027-01-01
- Completion
- 2027-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NCT03352323 ·Status: COMPLETED ·Phase: PHASE3
-
ADRN Barrier/Immunoprofiling Exploratory Pilot Study
NCT02115399 ·Status: COMPLETED
-
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980 ·Status: COMPLETED
-
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
NCT04853823 ·Status: UNKNOWN ·Phase: PHASE1
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
Clinical Evaluation of Bacitracin
NCT00132600 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Oral Steroids in the Treatment of Cellulitis
NCT00893048 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
NCT01518348 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
NCT05270512 ·Status: COMPLETED ·Phase: NA
-
Characterization of Chronic Hand Eczema
NCT05026554 ·Status: RECRUITING
-
Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
NCT07228962 ·Status: NOT_YET_RECRUITING
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA
-
KeraStat(R) Cream for Radiation Dermatitis
NCT03559218 ·Status: COMPLETED ·Phase: NA
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Registry for the Atopic Dermatitis Research Network
NCT01494142 ·Status: COMPLETED
-
An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses
NCT01736670 ·Status: COMPLETED ·Phase: NA
-
Multi-Centre European Photopatch Test Study
NCT00530387 ·Status: COMPLETED ·Phase: NA
-
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
NCT04202263 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis
NCT00643214 ·Status: COMPLETED ·Phase: NA
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA